Charles River Laboratories International, Inc.· CRL

🇺🇸 US · LargeSP500NYSE

Healthcare Medical - Diagnostics & Research Website

Price: $278.06
Day: -1.28%
Mkt Cap: $13.39B
52W Range: $144.26 – $303.31
Volume: 1.48M
Beta: 1.41

D35D Framework

Valuation Analysis

Intrinsic-value engines paired with peer-anchored multiples.

Valuation: 1.0 / 5 (Well above estimate); at $278.06 the price is 43% above the blended estimate of $157
Estimates: sector peers $157 (87 companies), own 10-year history $170
Multiples: EV/EBITDA 73.6x vs sector median 17.4x

Blog

Valuation Assessment

CRL Valuation Summary

How sector peers and the stock's own history value it (no intrinsic model available for this stock)

Overall valuation

1.0/5

Well above estimate

Market only · blended estimate

$157-43.5%

Based on the market evidence from peers and the stock's own history, the price is 43% above the market estimate.Last updated September 20, 2026.

Valuation Multiples

Per-metric breakdown of how CRL is priced relative to its sector peers, its own 10-year history, and analyst forward estimates.

Valuation context: This company is currently unprofitable at the net-income level. P/E isn't meaningful; focus on EV/EBITDA and EV/FCF above, with revenue multiples (P/S, EV/Sales) in the expanded section.

What sector peers imply

Value if it traded at the sector-median multiple

What its own history implies

Value if it traded at its own 10-year median multiple

How the Multiples lens works

Five primary multiples surface the headline call; five additional multiples sit one click deeper for context.

Valuation multiples compare a company's market price to its financial fundamentals. The primary grid covers both the equity perspective (P/E, PEG, FCF Yield) and the enterprise value perspective (EV/EBITDA, EV/FCF) so you see how the market prices the company two ways simultaneously.

Price-based multiples use market cap and reflect what equity investors pay. EV-based multiples include debt and are better for comparing companies with different capital structures. The expanded section below adds P/B, P/S, P/FCF, EV/EBIT, and EV/Sales for additional perspective.

Learn more about the 5D valuation methodology

Charles River Laboratories International, Inc.· CRL

Valuation Analysis

Valuation Multiples

Additional valuation multiples5 more metrics: P/B Ratio, P/S Ratio, P/FCF, EV/EBIT, EV/Sales

How implied prices are calculated

Primary multiples primer

Search stocks

Valuation Analysis

Valuation Multiples

Additional valuation multiples5 more metrics: P/B Ratio, P/S Ratio, P/FCF, EV/EBIT, EV/Sales

How implied prices are calculated

Primary multiples primer